Results 11 to 20 of about 158,510 (246)

Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup

open access: yesFrontiers in Immunology, 2023
Acute respiratory distress syndrome (ARDS) is an acute diffuse inflammatory lung injury characterized by the damage of alveolar epithelial cells and pulmonary capillary endothelial cells.
Huikang Xu   +4 more
semanticscholar   +1 more source

Corticosteroids in ARDS

open access: yesJournal of Clinical Medicine, 2023
Acute respiratory distress syndrome (ARDS) is frequently associated with sepsis. ARDS and sepsis exhibit a common pathobiology, namely excessive inflammation. Corticosteroids are powerful anti-inflammatory agents that are routinely used in septic shock and in oxygen-dependent SARS-CoV-2 related acute respiratory failure.
Kuperminc, Emmanuelle   +3 more
openaire   +4 more sources

Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis

open access: yesIntensive Care Medicine, 2021
Corticosteroids are now recommended for patients with severe COVID-19 including those with COVID-related ARDS. This has generated renewed interest regarding whether corticosteroids should be used in non-COVID ARDS as well. The objective of this study was
D. Chaudhuri   +19 more
semanticscholar   +1 more source

COVID-19 pneumonia: ARDS or not?

open access: yesCritical Care, 2020
Even though it can meet the ARDS Berlin definition [1, 2], the COVID-19 pneumonia is a specific disease with peculiar phenotypes. Its main characteristic is the dissociation between the severity of the hypoxemia and the maintenance of relatively good ...
L. Gattinoni, D. Chiumello, S. Rossi
semanticscholar   +1 more source

Classic Signaling Pathways in Alveolar Injury and Repair Involved in Sepsis-Induced ALI/ARDS: New Research Progress and Prospect

open access: yesDisease Markers, 2022
Sepsis is a common critical clinical disease with high mortality that can cause approximately 10 million deaths worldwide each year. Acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is a common clinical complication of sepsis, which ...
Wenli Li   +9 more
semanticscholar   +1 more source

Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series

open access: yesJournal of Thrombosis and Haemostasis, 2020
A prothrombotic coagulopathy is commonly found in critically ill COVID‐19 patients with acute respiratory distress syndrome (ARDS). A unique feature of COVID‐19 respiratory failure is a relatively preserved lung compliance and high Alveolar‐arterial ...
Janice Wang   +8 more
semanticscholar   +1 more source

COVID‐19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre‐COVID‐19 ARDS

open access: yesMedical Journal of Australia, 2020
“T his disease is still too strange to us, and there are too many doubts”, says Dr Ling Qin (LQ), after reviewing more than 400 patients with coronavirus disease 2019 (COVID19) pneumonia in Wuhan Union Hospital, China. COVID19 is a novel disease.
P. Gibson, Ling Qin, S. Puah
semanticscholar   +1 more source

Advances in the use of exosomes for the treatment of ALI/ARDS

open access: yesFrontiers in Immunology, 2022
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a critical clinical syndrome with high morbidity and mortality. Currently, the primary treatment for ALI/ARDS is mainly symptomatic therapy such as mechanical ventilation and fluid ...
Chang Liu, K. Xiao, L. Xie
semanticscholar   +1 more source

Acute respiratory failure in COVID-19: is it “typical” ARDS?

open access: yesCritical Care, 2020
In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) was identified in Wuhan, China. The World Health Organization (WHO) declared this outbreak a significant threat to international health.
Xu Li, Xiaochun Ma
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy